Stent

Global Carotid Stents Industry

Wednesday, October 21, 2020 - 12:15pm

Table 13: Carotid Stents Market in Europe: A Historic Market

Key Points: 
  • Table 13: Carotid Stents Market in Europe: A Historic Market
    Table 15: Carotid Stents Market in France: Estimates and
    Table 17: Carotid Stents Market in Germany: Recent Past,
    Table 21: United Kingdom Market for Carotid Stents: Annual
    Table 22: Carotid Stents Market in the United Kingdom: Historic
    Table 26: Carotid Stents Market in Russia: A Historic Review in
    Forecasts in US$ Thousand by Region/Country: 2020-2027
    Table 30: Carotid Stents Market in Asia-Pacific: Historic
    Table 32: Carotid Stents Market in Australia: Recent Past,
    Table 36: Carotid Stents Market in South Korea: Recent Past,
    Table 38: Rest of Asia-Pacific Market for Carotid Stents:
    Table 39: Carotid Stents Market in Rest of Asia-Pacific:
    Breakdown of Sales by Region/Country: 2012, 2020, and 2027
    Table 44: Carotid Stents Market in Argentina in US$ Thousand:
    Table 45: Carotid Stents Market in Brazil: Estimates and
    Table 47: Carotid Stents Market in Mexico: Recent Past, Current
    and Projections in US$ Thousand: 2020 to 2027
    Table 50: Carotid Stents Market in Rest of Latin America:
    Forecasts in US$ Thousand by Region/Country: 2020-2027
    Table 54: Iranian Market for Carotid Stents: Annual Sales
    Table 55: Carotid Stents Market in Iran: Historic Sales
    Table 57: Carotid Stents Market in Israel in US$ Thousand:
    Table 60: Carotid Stents Market in the United Arab Emirates:
    Table 62: Carotid Stents Market in Rest of Middle East: Recent
    Table 65: Carotid Stents Market in Africa: A Historic Review in

Global Bioabsorbable Stents Market Forecast 2020-2025 Featuring Key Players - Abbot Laboratories, Elixir Medical, Reva Medical, Kyoto Medical Planning - ResearchAndMarkets.com

Tuesday, October 20, 2020 - 9:28am

To overcome these roadblocks biodegradable stents came into existence in the recent years and is expected to considerably replace traditional stents.

Key Points: 
  • To overcome these roadblocks biodegradable stents came into existence in the recent years and is expected to considerably replace traditional stents.
  • The bioabsorbable stents market is classified on the basis of material used for manufacturing the products including polymeric and metallic.
  • Metal bioabsorbable stents are luring the medical device providers as they have the potential to perform similarly to stainless steel metal stents.
  • The key players in bioabsorbable stents market include:

OPTIMIZE Study Reports Lowest TLR Ever Achieved in an Investigational Device Exemption (IDE) Study With Svelte Medical System’s Bioresorbable Coated Drug-Eluting Coronary Stent

Saturday, October 17, 2020 - 5:00pm

The Svelte Drug-Eluting Stent (DES) achieved 1.5% clinically-driven Target Lesion Revascularization (TLR) at 1 year, the lowest ever reported in an Investigational Device Exemption (IDE) clinical study.

Key Points: 
  • The Svelte Drug-Eluting Stent (DES) achieved 1.5% clinically-driven Target Lesion Revascularization (TLR) at 1 year, the lowest ever reported in an Investigational Device Exemption (IDE) clinical study.
  • The high TLF reported in both OPTIMIZE treatment groups is driven by the 25% of study subjects assessed peri-procedurally with high-sensitivity-troponin.
  • We are deeply grateful to each and every one of the patients, investigative team members and support personnel contributing to the OPTIMIZE study.
  • Headquartered in New Providence, New Jersey, Svelte Medical Systems ( www.sveltemedical.com ) is a privately-held company engaged in the development of highly deliverable balloon expandable stents.

Global Peripheral Stents Market Insights to 2024 - Players Include Abbott, Biotronik and Boston Medical Among Others - ResearchAndMarkets.com

Friday, October 16, 2020 - 3:26pm

The "Global Peripheral Stents Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Peripheral Stents Market" report has been added to ResearchAndMarkets.com's offering.
  • This report was developed using extensive primary and secondary research by the publisher's analysts.
  • Data from proprietary databases, proprietary market reports, company reports, import/export databases, and secondary data sources on medical device markets were used to develop estimates of 2019 worldwide market size by product segment, ASPs, sales, and market share for the top suppliers by product segment.
  • Devices in this global market analysis include peripheral vascular stents, iliac artery stents, biliary stents, tracheobronchial stents.

Shockwave IVL Meets Safety and Effectiveness Endpoints in U.S. Coronary Pivotal IDE Study

Thursday, October 15, 2020 - 5:35pm

Disrupt CAD III is a prospective, multicenter, single-arm, global IDE study investigating the Shockwave Coronary IVL System in de novo, calcified, stenotic, coronary arteries prior to stenting.

Key Points: 
  • Disrupt CAD III is a prospective, multicenter, single-arm, global IDE study investigating the Shockwave Coronary IVL System in de novo, calcified, stenotic, coronary arteries prior to stenting.
  • Disrupt CAD III was based on a predicate study the single-arm ORBIT II IDE study of orbital atherectomy to develop performance goals that would allow FDA to evaluate the safety and effectiveness of IVL in a single arm study.
  • Coronary IVL prior to stent implantation was well tolerated with a low rate of major peri-procedural clinical and angiographic complications.
  • CAD III demonstrated the effectiveness of coronary IVL in treating calcium with large lumen gains that facilitated stent delivery.

Global Interventional Cardiology Devices Market (2020 to 2025) - Growth, Trends, and Forecasts - ResearchAndMarkets.com

Thursday, October 15, 2020 - 11:44am

The United States, currently, is expected to continue with its largest share in the coronary stents market.

Key Points: 
  • The United States, currently, is expected to continue with its largest share in the coronary stents market.
  • Much of the demand for and production of interventional cardiology devices are taken up by North America and Europe.
  • North America has a high consumption rate of premium-priced interventional cardiology devices, and it is the region that can cater to a high rate of innovation in medical devices, thus, dominating this market.
  • However, problems related to varying rates of degradation and uneven drug release have delayed the introduction of the bioabsorbable stents in the market.

Coronary Stents Pipeline Insight and Competitive Landscape Report 2020: Insights on 20+ Companies and Pipeline Devices - ResearchAndMarkets.com

Friday, October 9, 2020 - 12:48pm

The "Coronary Stents Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Coronary Stents Pipeline Insight and Competitive Landscape, 2020" drug pipelines has been added to ResearchAndMarkets.com's offering.
  • The Coronary Stents - Pipeline Insight and Competitive Landscape, 2020, report provides comprehensive insights about 20+ companies and 20+ pipeline devices in Coronary Stents pipeline landscape.
  • Owing to the rise in the prevalence of coronary artery diseases (CAD), the coronary stents market is witnessing remarkable growth.
  • This reports provides a detailed study of the emerging coronary stents devices along with competitive landscape to help better understand the market.

Cardiovascular Systems Announces Presentation of Data From Large Coronary Orbital Atherectomy Study at the TCT Connect 2020 Conference

Wednesday, October 7, 2020 - 12:00pm

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a large retrospective observational study of coronary orbital atherectomy will be released at TCT Connect 2020 .

Key Points: 
  • Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today that results from a large retrospective observational study of coronary orbital atherectomy will be released at TCT Connect 2020 .
  • This is a large retrospective observational study from a high volume, tertiary center treating complex severely calcified de novo coronary lesions that underwent lesion preparation with OAS before stent deployment.
  • Orbital Atherectomy System for Treating De Novo, Severely Calcified Coronary Lesions: A Tertiary Center Experience
    Please visit TCT Conference Hub - CSII to find information on all CSI activities at TCT Connect 2020.
  • CAD is a life-threatening condition and a leading cause of death in men and women in the United States.

China National Medical Products Administration (NMPA) Grants Innovative Medical Device Designation for VEST in China

Thursday, October 1, 2020 - 12:00pm

TEL AVIV, Israel, Oct. 1,2020 /PRNewswire/ --Vascular Graft Solutions Ltd. (VGS), an Israel-based innovative commercial-stage medical device company, announced today that the China National Medical Products Administration (NMPA) granted Innovative Medical Device Designation for VEST, an external stent for vein grafts in coronary artery bypass surgery.

Key Points: 
  • TEL AVIV, Israel, Oct. 1,2020 /PRNewswire/ --Vascular Graft Solutions Ltd. (VGS), an Israel-based innovative commercial-stage medical device company, announced today that the China National Medical Products Administration (NMPA) granted Innovative Medical Device Designation for VEST, an external stent for vein grafts in coronary artery bypass surgery.
  • "We are excited that VEST has been granted the Innovative Device Designation," said Eyal Orion, M.D., founder, and CEO of VGS.
  • "Only one out of five medical devices granted innovative device status by NMPA in 2019, of which only 20% were of overseas companies.
  • The innovative medical device designation provides a support platform for the assigned technologies to enter the Chinese market.

Bioabsorbable Stents Market 2020 - 2024: Post-Pandemic Industry Planning Structure | Technavio

Wednesday, September 23, 2020 - 3:15pm

The bioabsorbable stents market is expected to grow by USD 5.68 billion during 2020-2024, according to Technavio.

Key Points: 
  • The bioabsorbable stents market is expected to grow by USD 5.68 billion during 2020-2024, according to Technavio.
  • The report offers a detailed analysis of the impact of the COVID-19 pandemic on the bioabsorbable stents market in optimistic, probable, and pessimistic forecast scenarios.
  • View the full release here: https://www.businesswire.com/news/home/20200923005506/en/
    Technavio has announced its latest market research report titled Global Bioabsorbable Stents Market 2020-2024 (Graphic: Business Wire)
    The bioabsorbable stents market will witness Positive and Superior impact during the forecast period owing to the widespread growth of the COVID-19 pandemic.
  • Get report snapshot here to get detailed market share analysis of market participants during COVID-19 lockdown: https://www.technavio.com/report/ bioabsorbable stents market-industry-analysis
    Bioabsorbable Stents is segmented as below: